A translocation of the MYC oncogene, detected with fluorescent in situ hybridization (FISH) in approximately 10–15% of all DLBCL cases, is one of the genetic aberrations associated with inferior prognosis [7]. The gene discussed is MYC; the disease is diffuse large B-cell lymphoma.